Adsorption of Selected Antibiotics to Resins in Extracorporeal Blood Purification.
OBJECTIVE
Extracorporeal blood purification systems (EBS) use specific adsorbents for the elimination of toxins and cytokines. The aim of this study was to test different adsorbents for their ability to reduce antibiotics in parallel to extracorporeal blood purification therapy.


METHODS
The in vitro adsorption experiments were carried out in human plasma with a newly established hydrophobic resin (Amberchrom CG161c) and adsorbents commercially available and approved in the clinics. The concentration of antibiotic was chosen equivalent to the recommended therapeutic dosage applied intravenously and was measured in plasma using ELISA test kits and high-performance liquid chromatography methods.


RESULTS
The adsorbent that reduced all tested antibiotics in plasma close to the detection limit was the dia MARS AC250, which is an activated charcoal involved in the Molecular Adsorbents Recirculation System.


CONCLUSIONS
For better antibiotic monitoring in sepsis treatment, further investigations have to be performed to determine the clearance rate of antibiotics by different EBS devices.
Department for Health Sciences and Biomedicine, Danube University Krems, Krems, Austria.
Stephan
S
Harm
Anna
A
Gruber
Franz
F
Gabor
Jens
J
Hartmann
D000900:Anti-Bacterial Agents / Q000097:blood / Q000302:isolation & purification*; D002606:Charcoal / Q000737:chemistry; D024841:Fluoroquinolones / Q000097:blood / Q000302:isolation & purification*; D006020:Glycopeptides / Q000097:blood / Q000302:isolation & purification*; D006801:Humans; D008954:Models, Biological; D011108:Polymers / Q000737:chemistry; D006435:Renal Dialysis; D016060:Sorption Detoxification / Q000295:instrumentation* / Q000379:methods; D047090:beta-Lactams / Q000097:blood / Q000302:isolation & purification*
C552102:Amberchrom CG161 M; D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D006020:Glycopeptides; D011108:Polymers; D047090:beta-Lactams; D002606:Charcoal